Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation

115Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Background. Hypertension frequently complicates the use of cyclosporine A (CyA) therapy, and it has been suggested that sympathoexcitation may be the underlying mechanism in this form of hypertension. Methods and Results. To further investigate the possibility of a neurogenic mechanism for this hypertensive effect, we studied the effects of CyA on renal blood flow (n=11), forearm blood flow (n=8), and sympathetic nervous system activity, assessed by renal and whole-body radiolabeled norepinephrine plasma kinetics and muscle sympathetic nerve firing (using microneurography) in cardiac transplant recipients receiving CyA and a reference group of healthy age-matched control subjects (n=17). In 11 cardiac transplant patients (2 hours after cyclosporine dose), renal blood flow was significantly lower than that in 8 control subjects (680±88 vs 1285±58 mL/min, P

Cite

CITATION STYLE

APA

Kaye, D., Thompson, J., Jennings, G., & Esler, M. (1993). Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation. Circulation, 88(3), 1101–1109. https://doi.org/10.1161/01.cir.88.3.1101

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free